Evidence map›Paper›PMID 42105178›Full record

ArticleEJNMMI research2026

Integrated

Zhibo Dai, Yuhu Lv, Weiwei Ruan, Yongkang Gai, Xiaoli Lan, Chunxia Qin

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03756077 (A Prospective Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03756077 unknown statusnot on this map

A Prospective Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer

TypeobservationalSponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRan2018 to 2023Enrolled100ConditionsProstate Cancer, PET/MR, PET/CTArms68Ga-PSMA-11 and/or 18F-FDG PET/MR, PET/CT
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhibo DaiDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, Hubei Province, China.
Yuhu LvDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, Hubei Province, China.
Weiwei RuanDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, Hubei Province, China.
Yongkang GaiDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, Hubei Province, China.
Xiaoli LanDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, Hubei Province, China. xiaoli_lan@hust.edu.cn.
Chunxia QinDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, Hubei Province, China. qin_chunxia@hust.edu.cn.ORCID http://orcid.org/0000-0002-0291-4418

Funding

Hubei Province Science and Technology Innovation Team [2022] No. 72Key Project of Hubei Province Natural Science Foundation No. 2021CFA008National Natural Science Foundation of China No. 82472024
6 · The paper itself

Abstract

backgroundTo evaluate the diagnostic efficacy of

methodsA retrospective study was performed on patients who underwent ⁶⁸Ga-PSMA PET/MRI from November 2020 to April 2024, all with histopathological confirmation obtained from biopsy or prostatectomy. Parameters analyzed included SUV

resultsOf the 74 patients (mean age 65.9 ± 7.4 years), 52 had prostate cancer and 22 had benign lesions. PET parameters (SUV

conclusions

trial registrationNCT03756077. Registered 27 November 2018-Retrospectively registered, https://clinicaltrials.gov/show/NCT03756077 .

Indexed as

DiagnosisPET/MRIProstate cancerPSMAStratification

Identifiers

PMID42105178
PMCPMC13323478

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.